Performance monitoring of a wind turbine using extreme function theory

A power curve relates the power produced by a wind turbine to the wind speed. Usually, such curves are unique to the various types of wind turbines, so that by monitoring the power curves, one may monitor the performance of the turbine itself. Most approaches to monitoring a system or a structure at a basic level, generally aim at differentiating between a normal and an abnormal state. Typically, the normal state is represented by a model, and then abnormal, or extreme data points are identified when they are compared to that model. This comparison is very often done pointwise on scalars in the univariate case, or on vectors, if multivariate features are available. Depending on the actual application, the pointwise approach may be limited, or highly prone to false identifications. This paper presents the use of extreme functions for the performance monitoring of wind turbines. Power curves from an actual wind turbine, are assessed as whole functions, and not individual datapoints, with the help of Gaussian process regression and extreme value distributions, with the ultimate aim of the performance monitoring of the wind turbine at a weekly resolution. The approach is compared to the more conventional pointwise method, and approaches which make use of multivariate features, and is shown to be superior in terms of the number of false identifications, with a significantly lower number of false-positives without sacrificing the sensitivity of the approach

Aspects of structural health and condition monitoring of offshore wind turbines

Wind power has expanded significantly over the past years, although reliability of wind turbine systems, especially of offshore wind turbines, has been many times unsatisfactory in the past. Wind turbine failures are equivalent to crucial financial losses. Therefore, creating and applying strategies that improve the reliability of their components is important for a successful implementation of such systems. Structural health monitoring (SHM) addresses these problems through the monitoring of parameters indicative of the state of the structure examined. Condition monitoring (CM), on the other hand, can be seen as a specialized area of the SHM community that aims at damage detection of, particularly, rotating machinery. The paper is divided into two parts: in the first part, advanced signal processing and machine learning methods are discussed for SHM and CM on wind turbine gearbox and blade damage detection examples. In the second part, an initial exploration of supervisor control and data acquisition systems data of an offshore wind farm is presented, and data-driven approaches are proposed for detecting abnormal behaviour of wind turbines. It is shown that the advanced signal processing methods discussed are effective and that it is important to adopt these SHM strategies in the wind energy sector

A Performance Monitoring Approach for the Novel Lillgrund Offshore Wind Farm

The use of offshore wind farms has been growing in recent years. Europe is presenting a geometrically growing interest in exploring and investing in such offshore power plants as the continent's water sites offer impressive wind conditions. Moreover, as human activities tend to complicate the construction of land wind farms, offshore locations, which can be found more easily near densely populated areas, can be seen as an attractive choice. However, the cost of an offshore wind farm is relatively high, and therefore, their reliability is crucial if they ever need to be fully integrated into the energy arena. This paper presents an analysis of supervisory control and data acquisition (SCADA) extracts from the Lillgrund offshore wind farm for the purposes of monitoring. An advanced and robust machine-learning approach is applied, in order to produce individual and population-based power curves and then predict measurements of the power produced from each wind turbine (WT) from the measurements of the other WTs in the farm. Control charts with robust thresholds calculated from extreme value statistics are successfully applied for the monitoring of the turbines

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial.

Clarithromycin may act as immune-regulating treatment in sepsis and acute respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed to evaluate whether clarithromycin improves 28-day mortality among patients with sepsis, respiratory and multiple organ dysfunction syndrome. We conducted a multicenter, randomized, clinical trial in patients with sepsis. Participants with ratio of partial oxygen pressure to fraction of inspired oxygen less than 200 and more than 3 SOFA points from systems other than the respiratory function were enrolled between December 2017 and September 2019. Patients were randomized to receive 1 gr of clarithromycin or placebo intravenously once daily for 4 consecutive days. The primary endpoint was 28-day all-cause mortality. Secondary outcomes were 90-day mortality; sepsis response (defined as at least 25% decrease in SOFA score by day 7); sepsis recurrence; and differences in peripheral blood cell populations and leukocyte transcriptomics. Fifty-five patients were allocated to each arm. By day 28, 27 (49.1%) patients in the clarithromycin and 25 (45.5%) in the placebo group died (risk difference 3.6% [95% confidence interval (CI) - 15.7 to 22.7]; P = 0.703, adjusted OR 1.03 [95%CI 0.35-3.06]; P = 0.959). There were no statistical differences in 90-day mortality and sepsis response. Clarithromycin was associated with lower incidence of sepsis recurrence (OR 0.21 [95%CI 0.06-0.68]; P = 0.012); significant increase in monocyte HLA-DR expression; expansion of non-classical monocytes; and upregulation of genes involved in cholesterol homeostasis. Serious and non-serious adverse events were equally distributed. Clarithromycin did not reduce mortality among patients with sepsis with respiratory and multiple organ dysfunction. Clarithromycin was associated with lower sepsis recurrence, possibly through a mechanism of immune restoration. Clinical trial registration clinicaltrials.gov identifier NCT03345992 registered 17 November 2017; EudraCT 2017-001056-55

Towards population-based structural health monitoring, Part III: graphs, networks and communities

Population-based structural health monitoring opens up the possibility of using information from a population of structures to provide extra information for each individual structure. For example, population-based structural health monitoring could provide improved damage-detection within a homogeneous population of structures by defining a normal condition across a population of structures, which was robust to environmental variation. Furthermore, in cases where structures are sufficiently similar, damage location, assessment, and classification labels could be transferred, increasing the damage labels available for each structure. To determine whether two structures are sufficiently similar requires the comparison of some representation of the structure. In fields such as bioinformatics and computer science, attributed graphs are often used to determine structural similarity. This paper will describe methods for comparing the topology attributes of two such graphs. The algorithm described is suited to population-based structural health monitoring as it provides matches between two graphs which have physical significance. This paper will also describe the process of comparing hierarchical attributes to determine the level of knowledge transfer possible between two structures

The Relevance and Added Value of Geriatric Medicine (GM): Introducing GM to Non-Geriatricians

Geriatric Medicine (GM) holds a crucial role in promoting health and managing the complex medical, cognitive, social, and psychological issues of older people. However, basic principles of GM, essential for optimizing the care of older people, are commonly unknown or undermined, especially in countries where GM is still under development. This narrative review aims at providing insights into the role of GM to non-geriatrician readers and summarizing the main aspects of the added value of a geriatric approach across the spectrum of healthcare. Health practitioners of all specialties are frequently encountered with clinical conditions, common in older patients (such as cancer, hypertension, delirium, major neurocognitive and mental health disorders, malnutrition, and peri-operative complications), which could be more appropriately managed under the light of the approach of GM. The role of allied health professionals with specialized knowledge and skills in dealing with older people’s issues is essential, and a multidisciplinary team is required for the delivery of optimal care in response to the needs and aspirations of older people. Thus, countries should assure the educational background of all health care providers and the specialized health and social care services required to meet the demands of a rapidly aging society